KMSTF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

KADIMASTEM (KMSTF) Ownership - Who owns KADIMASTEM?

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Pinchas Sapir 7

Phone

+972 737971600

Employees

N/A

Web

http://www.kadimastem.com

Details

Group

Domestic Stock Funds

Fundamentals

KMSTF

Capitalization

28M

P/E Ratio

N/A

Risk (Beta)

-0.21

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

N/A

P/B Ratio

588.24

Cash Flow

N/A

Earnings

-2.8

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

0.70

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-9.53M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-115.17

Shares Held By Institutions

41.8K

Shares Outstanding - Current

4.19M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

-1

Gain YTD

-20.987

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology